2021-01-19

[#DIV28SUPER] FW: Final Recommendation Statement: Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons

Dear Colleagues,

 

The U.S. Preventive Services Task Force (USPSTF) just released final recommendations and an evidence summary on interventions for tobacco cessation in adults, including pregnant persons. A clinician summary is also available on the Task Force website, which provides guidance to primary care clinicians for using the recommendation in practice.

 

To view the recommendation and evidence summary, please click here:  https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions

 

Please forward to interested colleagues.

 

Thank you.

 

Jacob S. Marzalik, MA

Project Manager, Clinical Practice Guidelines

Practice Transformation and Quality, Practice Directorate

American Psychological Association

 

750 First Street NE, Washington, DC 20002-4242

202-336-5872

 

All APA staff are teleworking until further notice and are experiencing a high volume of inquiries related to COVID-19. For immediate information and resources, visit APA's COVID-19 page for psychologists, health-care workers, and the public.

 

From: Agency for Healthcare Research and Quality (AHRQ) <updates@subscriptions.ahrq.gov>
Sent: Tuesday, January 19, 2021 11:50 AM
To: Marzalik, Jacob <JMarzalik@apa.org>
Subject: Final Recommendation Statement: Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons

 

 

u s preventive services task force

January 19, 2021

Final Recommendation Statement:

Interventions for Tobacco Cessation in Adults

Final Recommendation Statement: Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons

The U.S. Preventive Services Task Force released today a final recommendation statement on interventions for tobacco smoking cessation in adults, including pregnant persons. The Task Force recommends clinicians ask about tobacco use and connect people to proven, safe methods to help them quit. The evidence is unclear whether e-cigarettes help adults quit smoking. More research is needed on the benefits and harms of using medications to help pregnant people quit. To view the recommendation, the evidence on which it is based, and a summary for clinicians, please go here. The final recommendation statement can also be found in the January 19, 2021 online issue of JAMA.

The Final Recommendation Statement Is Available

read the final recommendation

FINAL RECOMMENDATION SUMMARY

See the full statement

Population

Recommendation

Grade

Nonpregnant adults

The USPSTF recommends that clinicians ask all adults about tobacco use, advise them to stop using tobacco, and provide behavioral interventions and US Food and Drug Administration (FDA)--approved pharmacotherapy for cessation to nonpregnant adults who use tobacco.

A

Pregnant persons

The USPSTF recommends that clinicians ask all pregnant persons about tobacco use, advise them to stop using tobacco, and provide behavioral interventions for cessation to pregnant persons who use tobacco.

A

Pregnant persons

The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of pharmacotherapy interventions for tobacco cessation in pregnant persons.

I

All adults

he USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of electronic cigarettes (e-cigarettes) for tobacco cessation in adults, including pregnant persons. The USPSTF recommends that clinicians direct patients who use tobacco to other tobacco cessation interventions with proven effectiveness and established safety.

I

WHY THIS MATTERS

Michael Silverstein"Quitting is the most important step a smoker can take to lead a longer and healthier life,” says Task Force member Michael Silverstein, M.D., M.P.H. “The good news is there are multiple safe and proven ways to help adults quit tobacco, including counseling, medications, or a combination of both.”

WHERE WE ARE IN THE PROCESS

Draft

Research Plan

Final

Research Plan

Draft

Recommendation / Draft Evidence Review 

Final Recommendation / Evidence Summary


This email was sent to jmarzalik@apa.org using GovDelivery Communications Cloud on behalf of: Agency for Healthcare Research and Quality (AHRQ) · 5600 Fishers Lane, Rockville, MD 20857 · 301-427-1364 


CAUTION: This email originated from outside of the organization. Do not click links or open attachments unless you recognize the sender and know the content is safe.

No comments:

Post a Comment